CANF

$0.00

(

+0.00%

) Quote details
Add to Watchlist Run Backtest
stock

Can Fite Biopharma Ltd ADR

NYSE MKT | CANF

0.41

USD

+$0.00

(

+0.00%

)

At Close (As of Nov 5, 2025)

$15.74M

Market Cap

0

P/E Ratio

0

EPS

$2.37

52 Week High

$0.41

52 Week Low

HEALTHCARE

Sector

CANF Chart

Recent Chart
Price Action

CANF Technicals

Tags:

CANF Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $674K
Total Revenue $674K
Cost Of Revenue $7K
Costof Goods And Services Sold $7K
Operating Income -$8.1M
Selling General And Administrative $3M
Research And Development $5.8M
Operating Expenses $8.8M
Investment Income Net -
Net Interest Income $277K
Interest Income $291K
Interest Expense $14K
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $7K
Income Before Tax -$7.9M
Income Tax Expense -
Interest And Debt Expense -
Net Income From Continuing Operations -$7.9M
Comprehensive Income Net Of Tax -
Ebit -$8.1M
Ebitda -$8.1M
Net Income -$7.9M

Revenue & Profitability

Earnings Performance

CANF Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $9.1M
Total Current Assets $9M
Cash And Cash Equivalents At Carrying Value $4.8M
Cash And Short Term Investments $4.8M
Inventory -
Current Net Receivables $77K
Total Non Current Assets $138K
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets -
Intangible Assets Excluding Goodwill -
Goodwill -
Investments -
Long Term Investments -
Short Term Investments $3.1M
Other Current Assets $1M
Other Non Current Assets -
Total Liabilities $3.7M
Total Current Liabilities $2.1M
Current Accounts Payable $618K
Deferred Revenue -
Current Debt -
Short Term Debt $106K
Total Non Current Liabilities $1.6M
Capital Lease Obligations $104K
Long Term Debt -
Current Long Term Debt -
Long Term Debt Noncurrent -
Short Long Term Debt Total $104K
Other Current Liabilities $923K
Other Non Current Liabilities -
Total Shareholder Equity $5.4M
Treasury Stock -
Retained Earnings -$166M
Common Stock -
Common Stock Shares Outstanding $7.3M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow -$7.6M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $7K
Capital Expenditures $5K
Change In Receivables -
Change In Inventory -
Profit Loss -
Cashflow From Investment $1.5M
Cashflow From Financing $6.7M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$7.9M

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $674K
Total Revenue $674K
Cost Of Revenue $7K
Costof Goods And Services Sold $7K
Operating Income -$8.1M
Selling General And Administrative $3M
Research And Development $5.8M
Operating Expenses $8.8M
Investment Income Net -
Net Interest Income $277K
Interest Income $291K
Interest Expense $14K
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $7K
Income Before Tax -$7.9M
Income Tax Expense -
Interest And Debt Expense -
Net Income From Continuing Operations -$7.9M
Comprehensive Income Net Of Tax -
Ebit -$8.1M
Ebitda -$8.1M
Net Income -$7.9M

Dividends

Field Value
Ex Dividend Date 2013-11-12
Declaration Date None
Record Date None
Payment Date None
Amount 0.169622

CANF Profile

Can Fite Biopharma Ltd ADR Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

Can-Fite BioPharma Ltd. (CANF) is a clinical-stage biopharmaceutical company headquartered in Petah-Tikva, Israel, focused on developing innovative small molecule therapeutics targeting a range of serious illnesses, including cancer, liver and inflammatory diseases, COVID-19, and erectile dysfunction. With a robust pipeline anchored by clinical trials, Can-Fite is committed to addressing unmet medical needs through its proprietary drug candidates. The company’s technology platform leverages the unique mechanisms of action of its compounds to optimize therapeutic outcomes, positioning Can-Fite as a potentially significant player in the biopharmaceutical landscape.

CHR
-45.58%
$0.07
NVVE
-8.57%
$0.19
MTC
+626.97%
$2.21
ASST
+18.80%
$1.48
RIVN
+23.36%
$15.42
LNAI
+40.28%
$1.17
NVDA
-1.75%
$195.21
BYND
-4.31%
$1.33
VHAI
0.00%
$0.00
PFE
+1.37%
$24.63
RUBI
-49.75%
$0.30
SNAP
-2.00%
$7.32
PLUG
+4.76%
$2.64
TSLA
+4.00%
$462.07
GRAB
-2.50%
$5.64
YDKG
-5.55%
$0.05
F
+2.69%
$13.13
SMX
+43.53%
$2.11
PLTR
-1.48%
$187.90
INTC
+3.64%
$38.38
DNN
-2.18%
$2.68
WTO
-0.20%
$0.04
AXDX
-61.36%
$0.03
AMD
+2.51%
$256.33
ACHR
+0.26%
$9.58
GPUS
-7.02%
$0.34
T
+0.42%
$24.54
AAL
+6.08%
$13.42
BITF
+5.72%
$4.05
CMBM
+58.82%
$3.24
KVUE
+1.62%
$16.23
ONDS
+0.67%
$6.00
CIFR
+9.77%
$24.71
RXRX
-0.80%
$4.96
SOFI
+2.38%
$30.07
TEVA
+20.16%
$24.58
SMCI
-11.11%
$42.13
BAC
-2.04%
$52.44
ETHD
-15.01%
$4.47
ADAP
-15.14%
$0.05
NFE
+13.99%
$1.53
AMCR
+2.54%
$8.07
BTG
+1.12%
$4.04
WBD
+0.70%
$22.76
IREN
+14.67%
$76.41
AAPL
+0.03%
$270.14
MARA
+3.06%
$17.13
QS
+10.49%
$17.05
VALE
+3.09%
$12.31
DVLT
-7.83%
$1.64
CAN
+16.21%
$1.29
RIG
-0.12%
$3.89
RGTI
+5.99%
$37.29
U
+18.12%
$42.37
WULF
+2.33%
$15.36
RMBL
+60.50%
$3.21
FUBO
+11.00%
$4.08
AMZN
+0.35%
$250.20
ADD
-25.47%
$0.05
NVO
+0.43%
$48.46
BURU
-2.17%
$0.28
EPWK
-6.41%
$0.07
BTBT
+3.14%
$3.28
SRM
+53.27%
$10.30
TLRY
+3.62%
$1.28
BMNR
+4.89%
$41.39
NCLH
-0.95%
$18.61
JOBY
+0.98%
$14.90
ZDAI
+13.94%
$0.52
RIOT
-1.58%
$18.97
HIMS
+3.11%
$44.12
NOK
+0.51%
$6.84
APPS
+23.14%
$7.29
CMG
+0.72%
$31.97
HTZ
-0.81%
$6.67
ALIT
-7.22%
$2.50
HOOD
+4.15%
$142.47
QBTS
+4.37%
$31.04
NGD
+2.48%
$6.80
KDLY
-11.88%
$0.78
GOOGL
-2.17%
$277.54
NIO
+2.30%
$7.32
BBD
+3.47%
$3.52
BW
+28.34%
$4.80
NVTS
-5.73%
$9.86
WLGS
-5.57%
$0.04
MU
+8.93%
$237.50
HPE
+0.59%
$23.70
AG
-7.82%
$10.65
RDHL
+2.77%
$1.11
PLTZ
+2.80%
$6.24
GGB
+5.11%
$3.59
CPNG
-5.94%
$30.22
HBAN
+0.13%
$15.29
ETWO
0.00%
$3.30
PBR
+2.57%
$12.13
ABEV
+1.46%
$2.42
ITUB
+1.55%
$7.49
PCG
+1.57%
$16.16
MSPR
-27.89%
$0.47
CHR
-45.58%
$0.07
NVVE
-8.57%
$0.19
MTC
+626.97%
$2.21
ASST
+18.80%
$1.48
RIVN
+23.36%
$15.42
LNAI
+40.28%
$1.17
NVDA
-1.75%
$195.21
BYND
-4.31%
$1.33
VHAI
0.00%
$0.00
PFE
+1.37%
$24.63
RUBI
-49.75%
$0.30
SNAP
-2.00%
$7.32
PLUG
+4.76%
$2.64
TSLA
+4.00%
$462.07
GRAB
-2.50%
$5.64
YDKG
-5.55%
$0.05
F
+2.69%
$13.13
SMX
+43.53%
$2.11
PLTR
-1.48%
$187.90
INTC
+3.64%
$38.38
DNN
-2.18%
$2.68
WTO
-0.20%
$0.04
AXDX
-61.36%
$0.03
AMD
+2.51%
$256.33
ACHR
+0.26%
$9.58
GPUS
-7.02%
$0.34
T
+0.42%
$24.54
AAL
+6.08%
$13.42
BITF
+5.72%
$4.05
CMBM
+58.82%
$3.24
KVUE
+1.62%
$16.23
ONDS
+0.67%
$6.00
CIFR
+9.77%
$24.71
RXRX
-0.80%
$4.96
SOFI
+2.38%
$30.07
TEVA
+20.16%
$24.58
SMCI
-11.11%
$42.13
BAC
-2.04%
$52.44
ETHD
-15.01%
$4.47
ADAP
-15.14%
$0.05
NFE
+13.99%
$1.53
AMCR
+2.54%
$8.07
BTG
+1.12%
$4.04
WBD
+0.70%
$22.76
IREN
+14.67%
$76.41
AAPL
+0.03%
$270.14
MARA
+3.06%
$17.13
QS
+10.49%
$17.05
VALE
+3.09%
$12.31
DVLT
-7.83%
$1.64
CAN
+16.21%
$1.29
RIG
-0.12%
$3.89
RGTI
+5.99%
$37.29
U
+18.12%
$42.37
WULF
+2.33%
$15.36
RMBL
+60.50%
$3.21
FUBO
+11.00%
$4.08
AMZN
+0.35%
$250.20
ADD
-25.47%
$0.05
NVO
+0.43%
$48.46
BURU
-2.17%
$0.28
EPWK
-6.41%
$0.07
BTBT
+3.14%
$3.28
SRM
+53.27%
$10.30
TLRY
+3.62%
$1.28
BMNR
+4.89%
$41.39
NCLH
-0.95%
$18.61
JOBY
+0.98%
$14.90
ZDAI
+13.94%
$0.52
RIOT
-1.58%
$18.97
HIMS
+3.11%
$44.12
NOK
+0.51%
$6.84
APPS
+23.14%
$7.29
CMG
+0.72%
$31.97
HTZ
-0.81%
$6.67
ALIT
-7.22%
$2.50
HOOD
+4.15%
$142.47
QBTS
+4.37%
$31.04
NGD
+2.48%
$6.80
KDLY
-11.88%
$0.78
GOOGL
-2.17%
$277.54
NIO
+2.30%
$7.32
BBD
+3.47%
$3.52
BW
+28.34%
$4.80
NVTS
-5.73%
$9.86
WLGS
-5.57%
$0.04
MU
+8.93%
$237.50
HPE
+0.59%
$23.70
AG
-7.82%
$10.65
RDHL
+2.77%
$1.11
PLTZ
+2.80%
$6.24
GGB
+5.11%
$3.59
CPNG
-5.94%
$30.22
HBAN
+0.13%
$15.29
ETWO
0.00%
$3.30
PBR
+2.57%
$12.13
ABEV
+1.46%
$2.42
ITUB
+1.55%
$7.49
PCG
+1.57%
$16.16
MSPR
-27.89%
$0.47
2025 © AfterPullback LTD

Charts powered by TradingView

Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.